Labelling Review row-Online
Labelling Review row-Online
Labelling Review row-Online
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Human prostatic carcinoma: immunohistochemical staining for TNF-related apoptosisinducing<br />
ligand using NCL-TRAIL. Note cytoplasmic staining of a proportion of malignant<br />
cells. Paraffin section.<br />
Topoisomerase I<br />
Clone 1D6<br />
1 mL lyophilized NCL-TOPO I F P (HIER)<br />
Topoisomerases are nuclear enzymes involved in a variety of cellular<br />
activities such as chromosomal condensation, DNA replication, transcription,<br />
recombination and segregation at mitosis. Human topoisomerase I is a<br />
100 kD protein capable of relaxing positively and negatively supercoiled<br />
DNA by performing a transient single-stranded nick which is then re-ligated<br />
at the end of the reaction. It has been shown that the enzyme is located in<br />
regions of the genome that are undergoing active RNA synthesis where it<br />
probably reduces superhelical stresses in the DNA enabling RNA<br />
polymerase to function properly. In normal eukaryotic cells, DNA<br />
topoisomerase I does not show relevant fluctuations across the cell cycle,<br />
unlike DNA topoisomerase II alpha. Both DNA topoisomerases I and II have<br />
been found to be targets of autoantibodies in the sera of individuals with<br />
certain autoimmune diseases eg systemic lupus erythematosus and also of<br />
some anti-tumor drugs and antibiotics. Elevated levels of DNA<br />
topoisomerase I, detected by 32 P transfer assays, have been reported in<br />
colorectal tumors compared with normal colon mucosa as a result of<br />
increased transcription or mRNA stability.<br />
Product Specific Information<br />
The use of phosphate-containing wash buffers or diluents with NCL-TOPO I<br />
has an adverse effect on staining. Only Tris-containing wash buffers or<br />
diluents should be used.<br />
Topoisomerase II Alpha<br />
Clone 3F6<br />
1 mL, 0.1 mL lyophilized NCL-TOPOIIA F P (HIER) W<br />
Topoisomerase II alpha is an essential nuclear enzyme involved in DNA<br />
replication and is a target for many anti-cancer drugs used for cancer<br />
therapy. Decreased expression of topoisomerase II alpha is the predominant<br />
mechanism of resistance to several chemotherapeutic agents. A significant<br />
variation in the range of expression of this protein has been reported in<br />
many different tumors. Reports of the analysis of primary breast tumors have<br />
indicated that topoisomerase II beta is more widely expressed than<br />
topoisomerase II alpha. Topoisomerase II alpha expression and activity is<br />
linked to the cell cycle and is associated with the proliferation status of<br />
cells.<br />
Human bladder tumor: immunohistochemical staining for topoisomerase II alpha using<br />
NCL-TOPOIIA. Note intense nuclear staining of malignant cells and occasional mitotic<br />
figures. Paraffin section.<br />
Toxoplasma gondii P30 Antigen<br />
Clone TP3<br />
1 mL lyophilized NCL-TG P (HIER)<br />
Toxoplasma gondii is a ubiquitous protozoan parasite which can infect<br />
healthy humans, often asymptomatically, but may also cause severe<br />
congenital defects in the fetus and life-threatening infection in<br />
immunocompromised hosts. It has been shown that P30, also referred to as<br />
SAG-1, the major surface antigen of Toxoplasma gondii tachyzoites is<br />
involved in the first steps of invasion. This antigen has been reported to have<br />
generated interest as a potential subunit for vaccine production. P30 is a<br />
highly conserved antigen between most strains of Toxoplasma gondii.<br />
Infected human brain: immunohistochemical staining for Toxoplasma gondii P30 antigen using<br />
NCL-TG. Note staining of the parasites in infected areas. Paraffin section.<br />
F Frozen I Immunofluorescence E Electron microscopy<br />
P Paraffin C Flow cytometry O Other applications<br />
W Western blotting<br />
/ 165<br />
Primary Antibodies